76
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of SQ® HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany

, , , , &
Pages 77-84 | Published online: 16 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lin Yang & Rongfei Zhu. (2017) Immunotherapy of house dust mite allergy. Human Vaccines & Immunotherapeutics 13:10, pages 2390-2396.
Read now

Articles from other publishers (6)

Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen & Marek Jutel. (2022) Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies. Allergy 77:12, pages 3584-3592.
Crossref
V. V. Klimov, N. S. Koshkarova, V. S. Sviridova & A. V. Klimov. (2022) Allergen-specific immunotherapy in allergic rhinitis. Bulletin of Siberian Medicine 21:2, pages 168-174.
Crossref
Hiroshi Kumanomidou, Kengo Kanai, Aiko Oka, Takenori Haruna, Yuji Hirata, Sei-ichiro Makihara, Takaya Higaki, Maki Akamatsu, Yoshitaka Okamoto, Shunya Ikeda & Mitsuhiro Okano. (2022) Mapping naso-ocular symptom scores to EQ-5D-5L utility values in Japanese cedar pollinosis. Allergology International 71:2, pages 207-213.
Crossref
Linda S. Cox, Andrew Murphey & Cheryl Hankin. (2020) The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma. Immunology and Allergy Clinics of North America 40:1, pages 69-85.
Crossref
Katsuyo Ohashi-DoiKaare Lund, Yuko MitobeKazuhiro Okamiya. (2020) State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan. Biological and Pharmaceutical Bulletin 43:1, pages 41-48.
Crossref
. (2017) House dust mite SLIT cost effective for persistent allergic rhinitis. PharmacoEconomics & Outcomes News 772:1, pages 21-21.
Crossref